Neumora Therapeutics to Participate in Upcoming Conferences in November
30 Ottobre 2023 - 12:00PM
Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage
biopharmaceutical company redefining neuroscience drug development,
today announced that the Company will participate in two investor
conferences in November:
- Guggenheim Healthcare Talks 5th Annual INI
Conference: Members of management will participate in a
fireside chat on Monday, November 6, 2023, at 1:50 PM ET in New
York, NY.
- Stifel 2023 Healthcare Conference: Members of
management will participate in a fireside chat on Wednesday,
November 15, 2023, at 11:30 AM ET in New York, NY.
A live webcast of each event will be available on the events and
presentations section of the Company’s website at
www.neumoratx.com. A replay of the webcasts will be available
following the completion of the events and will be archived for up
to 30 days.
About NeumoraNeumora Therapeutics, Inc. is a
clinical-stage biopharmaceutical company founded to confront the
global brain disease crisis by taking a fundamentally different
approach to the way treatments for brain diseases are developed.
Neumora’s therapeutic pipeline currently consists of seven clinical
and preclinical neuroscience programs that target novel mechanisms
of action for a broad range of underserved neuropsychiatric
disorders and neurodegenerative diseases. Neumora’s work is
supported by an integrated suite of translational, clinical, and
computational tools to generate insights that can enable precision
medicine approaches. Neumora’s mission is to redefine neuroscience
drug development by bringing forward the next generation of novel
therapies that offer improved treatment outcomes and quality of
life for patients suffering from brain diseases. For additional
information, please visit www.neumoratx.com and follow on
Twitter: @NeumoraTx.
Neumora ContactHelen
RubinsteinHelen.Rubinstein@neumoratx.com315-382-3979
Grafico Azioni Neumora Therapeutics (NASDAQ:NMRA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Neumora Therapeutics (NASDAQ:NMRA)
Storico
Da Giu 2023 a Giu 2024